| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 30,901 | 40,528 | 45,132 | 56,793 | | Cost of Revenue | 25,001 | 32,543 | 36,048 | 45,835 | | | Gross Profit | 5,900 | 7,985 | 9,084 | 10,958 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,886 | 10,318 | 11,029 | 11,678 | | Non Recurring | 917 | 3,993 | 66 | 6,501 | | Others | 44 | 224 | 223 | 234 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,947) | (6,550) | (2,234) | (7,455) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8 | 13 | 14 | 24 | | Earnings Before Interest And Taxes | (3,939) | (6,537) | (2,220) | (7,431) | | Interest Expense | 9 | 3 | 8 | 13 | | Income Before Tax | (3,948) | (6,540) | (2,228) | (7,444) | | Income Tax Expense | 13 | 12 | 6 | 121 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,961) | (6,552) | (2,234) | (7,565) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,961) | (6,552) | (2,234) | (7,565) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,961) | ($6,552) | ($2,234) | ($7,565) |
|
0.26% Nasdaq 
0.01 (1.88%) 
Income Statement
